Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Expert Rev Hematol. 2011 Dec;4(6):597–606. doi: 10.1586/ehm.11.61

Table 2.

Risk factors for hemorrhagic stroke in sickle cell disease.

Study (year) Risk factor Odds ratio (95% CI) p-value Participants Comments Ref.
Ohene-Frempong et al. (1998) Steady-state Hb (for every 1 g/dl decrease) 1.6 (1.1–2.4) 0.013 2436 children and adults with HbSS Did not report children and adults separately [3]
Steady-state leukocyte count for every 5000/μl increase) 1.9 (1.7–2.2) 0.026

Strouse et al. (2009) Hypertension NC (1.7–NC) <0.05 15 children with hemorrhagic and 29 with ischemic stroke Case–control study [12]
Events in the last 14 days
 Transfusion of RBCs 35 (4.9–289) <0.001
 Corticosteroids 20 (2.9–217) <0.005
 NSAIDs 4.4 (0.9–21) <0.05

Strouse et al. (2008) Transfusion in last 14 days 15 (1.5–708) <0.01 20 adults with hemorrhagic and 29 with ischemic stroke Case–control study [17]

Strouse et al. (2009) Hypertension 7.7 (4.7–13) <0.0001 255 acute strokes among 69,586 discharges with sickle cell disease Did not report children and adults separately [7]
Renal disease 7.2 (3.4–14) <0.0001
Coagulopathy 9.1 (2.8–23) <0.0005
Atrial fibrillation 4.3 (0.9–13) <0.05

Hb: Hemoglobin; HbSS: Sickle cell anemia; NC: Not calculated; RBC: Red blood cell.